Safety Profile of the New 5-ASA Based Compounds
5-aminosalicylic acid (5-ASA) preparations were anticipated to be and generally are better tolerated than sulphasalazine. Minor side effects such as headache, dizziness, abdominal pain and nausea do occur but are not more frequent than in placebo-treated patients. Approximately 10% of patients thoug...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1990-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1990/345274 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552679907262464 |
|---|---|
| author | Vinod K Sharma |
| author_facet | Vinod K Sharma |
| author_sort | Vinod K Sharma |
| collection | DOAJ |
| description | 5-aminosalicylic acid (5-ASA) preparations were anticipated to
be and generally are better tolerated than sulphasalazine. Minor side effects such
as headache, dizziness, abdominal pain and nausea do occur but are not more
frequent than in placebo-treated patients. Approximately 10% of patients
thought to be allergic to sulphasalazine are also allergic to 5-ASA. An
idiosyncratic reaction with worsening of symptoms can occur. Diarrhea is more
common with olsalazine, and it is due to the effect of olsalazine itself on the small
bowel. not the 5-ASA component. There are case reports of pancreatitis,
pericarditis and bronchospasm, retrosternal chest pain, mild neutropenia,
nephrotic syndrome and hair loss associated with 5-ASA treatment. Patients
with oligospermia due to sulphasalazine have improved when switched to 5-ASA. 5-ASA enemas can cause local irritation or other effects resulting from
enema tip insertion. |
| format | Article |
| id | doaj-art-fc40d40fcc0e4de8afeda0c800425d1c |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 1990-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-fc40d40fcc0e4de8afeda0c800425d1c2025-02-03T05:58:07ZengWileyCanadian Journal of Gastroenterology0835-79001990-01-014744344510.1155/1990/345274Safety Profile of the New 5-ASA Based CompoundsVinod K Sharma5-aminosalicylic acid (5-ASA) preparations were anticipated to be and generally are better tolerated than sulphasalazine. Minor side effects such as headache, dizziness, abdominal pain and nausea do occur but are not more frequent than in placebo-treated patients. Approximately 10% of patients thought to be allergic to sulphasalazine are also allergic to 5-ASA. An idiosyncratic reaction with worsening of symptoms can occur. Diarrhea is more common with olsalazine, and it is due to the effect of olsalazine itself on the small bowel. not the 5-ASA component. There are case reports of pancreatitis, pericarditis and bronchospasm, retrosternal chest pain, mild neutropenia, nephrotic syndrome and hair loss associated with 5-ASA treatment. Patients with oligospermia due to sulphasalazine have improved when switched to 5-ASA. 5-ASA enemas can cause local irritation or other effects resulting from enema tip insertion.http://dx.doi.org/10.1155/1990/345274 |
| spellingShingle | Vinod K Sharma Safety Profile of the New 5-ASA Based Compounds Canadian Journal of Gastroenterology |
| title | Safety Profile of the New 5-ASA Based Compounds |
| title_full | Safety Profile of the New 5-ASA Based Compounds |
| title_fullStr | Safety Profile of the New 5-ASA Based Compounds |
| title_full_unstemmed | Safety Profile of the New 5-ASA Based Compounds |
| title_short | Safety Profile of the New 5-ASA Based Compounds |
| title_sort | safety profile of the new 5 asa based compounds |
| url | http://dx.doi.org/10.1155/1990/345274 |
| work_keys_str_mv | AT vinodksharma safetyprofileofthenew5asabasedcompounds |